Parthenon LLC’s Cellebrite CLBT Stock Holding History

Parthenon LLC’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$837K	Buy	+74,334	New	+$989K	0.09%	82

Other funds holding CLBT

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

CCAM

Capelight Capital Asset Management New York $254M AUM 164.28% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Pension & Wealth Management Advisors Waltham, Massachusetts $441M AUM 9.69% 1-Year Est. Return

Harmony Asset Management Scottsdale, Arizona $398M AUM 31.23% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Parthenon LLC's CLBT Position: Q3 2026 in Review

Parthenon LLC opened a new position in Cellebrite (CLBT) in Q3 2026: 74,334 shares worth $837K. The stake represents 0.09% of the portfolio and ranks #82 among its holdings.

21 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

Parthenon LLC held 74,334 shares of Cellebrite worth $837K as of Q3 2026.
Cellebrite was a new Parthenon LLC position in Q3 2026.
Cellebrite made up 0.09% of Parthenon LLC's portfolio in Q3 2026, its #82 holding.
21 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Parthenon LLC's 13F filing for Q3 2026, filed 22 Oct 2026.